Salud financiera de hoja de balance de Nath Bio-Genes (India)
Salud financiera controles de criterios 4/6
Nath Bio-Genes (India) tiene un patrimonio de accionistas total de ₹6.4B y una deuda total de ₹1.3B, lo que sitúa su ratio deuda-patrimonio en 19.9%. Sus activos y pasivos totales son ₹8.3B y ₹1.9B respectivamente. El BAIT de Nath Bio-Genes (India) es de ₹461.8M, por lo que su ratio de cobertura de intereses es de 5.5. Tiene efectivo e inversiones a corto plazo que ascienden a ₹20.8M.
Información clave
19.9%
Ratio deuda-patrimonio
₹1.27b
Deuda
| Ratio de cobertura de intereses | 5.5x |
| Efectivo | ₹20.77m |
| Patrimonio | ₹6.40b |
| Total pasivo | ₹1.88b |
| Activos totales | ₹8.28b |
Actualizaciones recientes sobre salud financiera
These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Jun 27
Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Recent updates
Here's Why Shareholders Should Examine Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) CEO Compensation Package More Closely
Aug 11Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Solid Earnings May Rest On Weak Foundations
Jul 31Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Shares Fly 34% But Investors Aren't Buying For Growth
Jul 02These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Jun 27Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has More To Do To Multiply In Value Going Forward
Apr 05Returns On Capital At Nath Bio-Genes (India) (NSE:NATHBIOGEN) Have Hit The Brakes
Oct 24Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has Some Way To Go To Become A Multi-Bagger
Jun 07Some Investors May Be Worried About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Feb 11We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital Not Reflecting Well On The Business
Jun 19Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Returns On Capital Signal Tricky Times Ahead For Nath Bio-Genes (India) (NSE:NATHBIOGEN)
May 27Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28The Trends At Nath Bio-Genes (India) (NSE:NATHBIOGEN) That You Should Know About
Feb 07Declining Stock and Decent Financials: Is The Market Wrong About Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)?
Jan 19The Nath Bio-Genes (India) (NSE:NATHBIOGEN) Share Price Is Up 149% And Shareholders Are Boasting About It
Jan 01Why Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay Matters
Dec 14
These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Here's What To Make Of Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Nov 05Do Its Financials Have Any Role To Play In Driving Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) Stock Up Recently?
Oct 15Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Might Not Be As Mispriced As It Looks After Plunging 25%
Sep 24Many Still Looking Away From Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
Sep 08Introducing Nath Bio-Genes (India) (NSE:NATHBIOGEN), The Stock That Soared 311% In The Last Five Years
Sep 07Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Doing What It Can To Lift Shares
Aug 18Here's What We Think About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay
Jul 26Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹5.2B) de NATHBIOGEN superan a sus pasivos a corto plazo (₹1.8B).
Pasivo a largo plazo: Los activos a corto plazo de NATHBIOGEN (₹5.2B) superan a sus pasivos a largo plazo (₹68.6M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (19.6%) de NATHBIOGEN se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de NATHBIOGEN ha crecido de 12.2% a 19.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de NATHBIOGEN no está bien cubierta por el flujo de caja operativo (8.8%).
Cobertura de intereses: Los pagos de intereses de la deuda de NATHBIOGEN están bien cubiertos por el BAIT (5.5x cobertura).